The Regulatory Questionnaire profile defines a structured, machine-readable format for regulatory questions issued by a health authority during the review of a regulatory submission. This resource enables automated routing, tracking, and response management while preserving rich formatting and traceability to the Common Technical Document (CTD) structure.
Participants & Contacts/div>
Regulatory Affairs Division
NRA Headquarters
Global Regulatory Affairs Group
Basel, Switzerland
ISSUING AUTHORITY
National Regulatory AuthorityRegulatory Affairs Division
NRA Headquarters
RECIPIENT MAH
SynthPharma AGGlobal Regulatory Affairs Group
Basel, Switzerland
Module 1: Administrative Information
1
Is the variation fee fully paid and documented?
Confirmation of payment received by the regulatory authority finance office.
Module 3.2.P.7: Container Closure System
2
Any changes in the packaging configuration during stability?
[Draft Figure: Alu/Alu Blister Cross-section]
| Original Pack | Proposed Pack |
|---|---|
| PVC/PVDC Blister | Alu/Alu Blister |
Module 3: Quality - Stability
3
Are there any new stability studies conducted or only additional timepoints?
Reference: ICH Q1A(R2). Response provided on Dec 15, 2024.
4
Does the data support all intended climatic zones?
Confirm coverage for Zone IVb (30°C/75% RH) per WHO TRS 1010. Provide summary for all tested climatic conditions.